Sona Nanotech Walks From Rapid Saliva Test After Poor Study Results
Sona Nanotech (CSE: SONA) last night finally announced it is waving the white flag on its COVID-19 rapid saliva test.
Read more
Sona Nanotech
Sona Nanotech Halts COVID-19 Rapid Saliva Test Trials, Drops Research Program
Sona Nanotech (CSE: SONA) this morning had bombshell news, in that it has discontinued its clinical trial for a COVID-19
Read more
Clinical Trials To Begin For Sona Nanotech’s COVID-19 Rapid Saliva Test
Sona Nanotech Inc. (CSE: SONA) announced after market close last night that it has received the go signal from the
Read more
Sona Nanotech Approved For Clinical Trials of Saliva-Based COVID-19 Rapid Test
Sona Nanotech (CSE: SONA) has been approved to begin clinical trials. The company this morning announced that Health Canada has
Read more
Sona Nanotech’s Rapid Antigen Test Approved For Sale In Europe Via CE Mark Approval
Sona Nanotech (CSE: SONA) has been granted CE Mark status for its rapid COVID-19 antigen test. The implication of receiving
Read more
Sona Nanotech Announces $2.0 Million Private Placement
Sona Nanotech (CSE: SONA) this morning announced that it is looking to raise funds via a private placement. The company
Read more
Sona Nanotech: Health Canada Evaluation Results Did Not Match Prior Analytical And Clinical Study Data
Sona Nanotech (CSE: SONA) this morning elaborated on its decision to withdraw its antigen test from an application for an
Read more
Sona Nanotech Withdraws Health Canada Application For COVID-19 Test Due To Feedback From Regulator
In what is a major blow to shareholders of Sona Nanotech (CSE: SONA), the company this afternoon announced that it
Read more
Market Movers: Canadian Small Cap COVID-19 Stocks Take A Beating
COVID-19 related stocks are all the rage this morning, however it appears to be for the wrong reason. Following the
Read more
Sona Nanotech Rejected By FDA For Emergency Use Authorization
The US Food and Drug Administration has rejected Sona Nanotech’s (CSE: SONA) request for an emergency use authorization for the
Read more